Publications by authors named "Kenneth C Turner"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

316,518

Total Likes

7,342

Extended Reach

2,338,114

Social Features

271
T
The Effects of Fasinumab on Peripheral Nerve Function and Ganglion Anatomy: Results From a Randomized, Double-Blind, Placebo-Controlled Study in Patients With Pain Due to Osteoarthritis of the Knee or Hip, and a Series of Nonclinical Studies.
Simon Eng, Michael Fetell, Haitao Gao, Jingning Mei, Jesus Trejos, Kenneth C Turner

Curr Ther Res Clin Exp· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Immunogenicity and Drug Exposure and the Importance of Target Engagement in ADA Development: A Clinical Case Study of Anti-SARS-CoV-2 Biotherapeutics.
Susan C Irvin, Samit Ganguly, Zhiqiang Wang, Zhongqing Will He, Marguerite Alejandro, Kenneth C Turner

AAPS J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of fasinumab in an NSAID-controlled study in patients with pain due to osteoarthritis of the knee or hip.
Stephen J DiMartino, Haitao Gao, Simon Eng, Guillermo Valenzuela, Thomas Fuerst, Kenneth C Turner

BMC Musculoskelet Disord· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase III study to evaluate the long-term safety and efficacy of fasinumab in patients with pain due to osteoarthritis of the knee or hip.
Stephen J DiMartino, Jingning Mei, Thomas J Schnitzer, Haitao Gao, Simon Eng, Kenneth C Turner

Osteoarthr Cartil Open· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Pharmacokinetics of Casirivimab and Imdevimab (CAS + IMD) in Pediatric Outpatients With COVID-19.
Thomas D Norton, Mazhar Thakur, Samit Ganguly, Shazia Ali, Jesse Chao, Kenneth C Turner

J Pediatric Infect Dis Soc· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetics of Casirivimab and Imdevimab in Pediatric and Adult Non-Infected Individuals, Pediatric and Adult Ambulatory or Hospitalized Patients or Household Contacts of Patients Infected with SARS-COV-2.
Kuan-Ju Lin, Kenneth C Turner, Maria Rosario, Lutz O Harnisch, John D Davis

Pharm Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the safety and pharmacokinetics of casirivimab and imdevimab (CAS+IMD) in a cohort of pregnant outpatients with COVID-19: results from an adaptive, multicentre, randomised, double-blind, phase 1/2/3 study.
Thomas D Norton, Mazhar Thakur, Samit Ganguly, Shazia Ali, Jesse Chao, Kenneth C Turner

BMJ Open· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic exposure to aflibercept after intravitreal injection in premature neonates with retinopathy of prematurity: results from the FIREFLEYE randomized phase 3 study.
Andreas Stahl, Noriyuki Azuma, Wei-Chi Wu, Domenico Lepore, Emine Sukgen, Kenneth C Turner

Eye (Lond)· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetics of Fasinumab in Healthy Volunteers and Patients With Pain Due to Osteoarthritis of the Knee or Hip.
Kuan-Ju Lin, Kenneth C Turner, Hazem E Hassan, Lutz O Harnisch, John D Davis

Clin Pharmacol Drug Dev· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Systemic exposure to aflibercept after intravitreal injection in premature neonates with retinopathy of prematurity: results from the FIREFLEYE randomized phase 3 study.
Andreas Stahl, Noriyuki Azuma, Wei-Chi Wu, Domenico Lepore, Emine Sukgen, Kenneth C Turner

Eye (Lond)· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration.
Dean Follmann, Meagan P O'Brien, Jonathan Fintzi, Michael P Fay, David Montefiori, Kenneth C Turner

Nat Commun· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoclonal antibodies against GFRα3 are efficacious against evoked hyperalgesic and allodynic responses in mouse join pain models but, one of these, REGN5069, was not effective against pain in a randomized, placebo-controlled clinical trial in patients with osteoarthritis pain.
Selin Somersan-Karakaya, Kenneth C Turner, Luz Cortes-Burgos, Jutta Miller, Michael LaCroix-Fralish

Neurobiol Pain· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Casirivimab and Imdevimab for the Treatment of Hospitalized Patients With COVID-19.
Selin Somersan-Karakaya, Eleftherios Mylonakis, Vidya P Menon, Jason C Wells, Shazia Ali, Kenneth C Turner

J Infect Dis· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial.
Gary A Herman, Meagan P O'Brien, Eduardo Forleo-Neto, Neena Sarkar, Flonza Isa, Kenneth C Turner

Lancet Infect Dis· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19.
Flonza Isa, Eduardo Forleo-Neto, Jonathan Meyer, Wenjun Zheng, Scott Rasmussen, Kenneth C Turner

Int J Infect Dis· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virologic Efficacy of Casirivimab and Imdevimab COVID-19 Antibody Combination in Outpatients With SARS-CoV-2 Infection: A Phase 2 Dose-Ranging Randomized Clinical Trial.
Cynthia Portal-Celhay, Eduardo Forleo-Neto, Will Eagan, Bret J Musser, John D Davis, Kenneth C Turner

JAMA Netw Open· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.
Meagan P O'Brien, Eduardo Forleo-Neto, Neena Sarkar, Flonza Isa, Peijie Hou, Kenneth C Turner

JAMA· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19.
David M Weinreich, Sumathi Sivapalasingam, Thomas Norton, Shazia Ali, Haitao Gao, Kenneth C Turner

N Engl J Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
REGEN-COV antibody cocktail bioanalytical strategy: comparison of LC-MRM-MS and immunoassay methods for drug quantification.
Susan C Irvin, Samit Ganguly, Rachel Weiss, Chinnasamy Elango, Xuefei Zhong, Kenneth C Turner

Bioanalysis· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous REGEN-COV Antibody Combination in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.
Meagan P O'Brien, Eduardo Forleo-Neto, Neena Sarkar, Flonza Isa, Peijie Hou, Kenneth C Turner

medRxiv· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.
Meagan P O'Brien, Eduardo Forleo-Neto, Bret J Musser, Flonza Isa, Kuo-Chen Chan, Kenneth C Turner

N Engl J Med· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous REGEN-COV Antibody Combination for Covid-19 Prevention.
Meagan P O'Brien, Eduardo Forleo-Neto, Bret J Musser, Flonza Isa, Kuo-Chen Chan, Kenneth C Turner

medRxiv· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching from rivaroxaban to warfarin: an open label pharmacodynamic study in healthy subjects.
Kenneth Todd Moore, William Byra, Seema Vaidyanathan, Jaya Natarajan, Jay Ariyawansa, Kenneth C Turner

Br J Clin Pharmacol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open-label study to estimate the effect of steady-state erythromycin on the pharmacokinetics, pharmacodynamics, and safety of a single dose of rivaroxaban in subjects with renal impairment and normal renal function.
Kenneth T Moore, Seema Vaidyanathan, Jaya Natarajan, Jay Ariyawansa, Lloyd Haskell, Kenneth C Turner

J Clin Pharmacol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis